News
CPL appoints Brian Lankadurai as Director, Product Development Services
At CPL, our goal is to be the very best topical and non-sterile liquid CDMO in the world. In order to be the best, we have built an experienced team of experts that can guide our customers’ products through the development, scale-up, and commercial manufacturing stages. We are proud of our team and want to […]
Events
Dermatology Drug Development Summit-2021
CPL will be attending the Dermatology Drug Development Summit, sponsored by Hanson Wade, in Boston, Massachusetts, November 17th and 18th. Many of the leading dermatology drug companies will be attending this exciting two day summit to share perspectives, insights, and information on the current issues surrounding the development of new dermatology therapeutics. CPL will have a […]
Resources
CPL shares expertise on topical semi-solid product development with Critical Process Parameter studies
As the skin is the largest organ in the human body, it presents a potential target for a number of pharmaceutical compounds intended to treat a variety of diseases and conditions. There are multiple different layers to target, several drug penetration routes, and a variety of topically-delivered product formulations-creams, ointments, gels, and lotions—to choose from […]
Resources
Contract Pharmaceuticals Limited, the one-stop shop for innovation
Growing pressure in the pharmaceutical industry for quicker delivery times for products to reach market, while at the same time reducing costs, is leading an increasing number of companies to outsource a range of product activities to third parties, from development through to commercialisation. And with an array of available partners specialising in each of […]
Resources
The CMO Serialization Perspective Utilizing a Standardized Approach for Efficient Partner Onboarding
CPL-Poster-Session-printable
News
CPL Completes Successful Virtual Health Canada Audit
June 2, 2021, Mississauga, Ontario, Canada— Contract Pharmaceuticals Limited Canada (CPL), a Health Canada and US FDA inspected manufacturer of liquid and semi-solid prescription and regulated OTC products, has successfully completed a virtual cGMP audit of its manufacturing facility by Health Canada. Since the onset of the global pandemic, CPL has focused on keeping our […]
News
CPL Launches Production of Hand-Sanitizer to Meet Critical Shortages
Mississauga, Ontario, Canada, April 9, 2020 — Contract Pharmaceuticals Limited Canada (CPL), a Health Canada and US FDA approved manufacturer of liquid and semi-solid prescription and OTC medicines, has begun production of its alcohol-based hand sanitizer to help meet the current market shortage during the ongoing COVID-19 pandemic. With the urgent need for hand sanitizer […]
News
CPL Introduces New Skin Lab for Topical Pharmaceutical Product Testing
Sujata Syam has been leading a group of scientists in building CPL’s newest service offering—testing of topical pharmaceutical products using skin-based technologies and approaches. Sujata joined CPL in 2015 to head up the Skin Lab within the Product Development Services group. Sujata has more than 20 years of experience in proteins, assay development and therapeutics. […]
News
CPL’s State-or-the-Art Commercial Manufacturing and Packaging Equipment
November 1, 2019–MISSISSAGUA, ONTARIO — CPL is a provider of pharmaceutical product development and commercial manufacturing services focused on non-sterile liquid and semi-solid dosage forms. In order to further establish itself as the leader in these dosage forms, the company’s Symex manufacturing vessels and new commercial filling lines for products packaged into tubes and bottles […]